RadSep’s Purification and Molecular Recognition Technology
February 19, 2026
RadSep, Inc., a subsidiary of IBC Advanced Technologies, Inc., provides state-of-the-art purification technology and novel chelators for medical radioisotopes and their precursors (Ac-225, Ra-224, Ra-225, Ra-226, Ra-228, Th-228, Th-232, Pb-212, Cu-67, and more).
RadSep offers Molecular Recognition Technology™ (MRT™) resins that are extremely selective, stable and simple to use. First-pass recoveries and purities of 99.9+% are achieved due to the high selectivity and capacity of MRT™ resins. In addition, their high radiolytic stability enables reuse for multiple separation cycles. MRT™ separation systems deliver maximum useable activity while minimizing manufacturing space and waste. Thus, MRT™ makes radioisotope production compatible with radiopharmaceutical manufacturing at scale.
As an award-winning manufacturer, RadSep also offers highly selective chelators for various radioisotopes.
Learn more at https://radsep.com
Recent News
- Nucleus Institute Convergence Point Groundbreaking
- EDWARDS LIFESCIENCES RECEIVES FDA APPROVAL FOR AUTUS VALVE
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
